Elligo Health Research will test a harmonized real-word data model built by the FDA.

A recent study by the Tufts Center for the Study of Drug Development found that EDC systems still aren't efficiently accelerating clinical trials.

Biopharma intelligence firm Ozmosi has launched a database that aims to include almost all clinical trials around the world.

Antidote, which develops an online platform to match patients with researchers, just raised $11 million backed by Merck's GHI fund.

Parexel has set up a team committed to providing real-world data insights.

Outcome Health has tapped Harvard Health Publications to improve and expand its health intelligence offerings.

WIRB-Copernicus Group has bought Patient Genesis’ eConsent technology, ConsentNow.

PRA will buy health data and analytics expert Symphony Health for $530 million up front as it reports 16% second-quarter service revenue growth.

BeiGene is adding Medidata’s electronic patient-reported outcome solution to oncology clinical studies.